Rachel J Cook - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

Rachel J Cook

Showing results (31-40 of 32) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 32 results.

Blood Neoplasia|April 20, 2026

Results of a phase 1 trial testing ruxolitinib plus venetoclax in patients with relapsed/refractory acute myeloid leukemiaUma Borate, Cristina E Tognon, Yazan F Madanat, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2026

Risk Prognostication After Hypomethylating Agents Combined With Venetoclax in AML: The PRISM Risk ModelCurtis A Lachowiez, Joshua F Zeidner, Jad Othman, et al.

Pageof 4

Search research articles

Showing results (31-40 of 32) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 32 results.

Blood Neoplasia|April 20, 2026

Results of a phase 1 trial testing ruxolitinib plus venetoclax in patients with relapsed/refractory acute myeloid leukemiaUma Borate, Cristina E Tognon, Yazan F Madanat, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2026

Risk Prognostication After Hypomethylating Agents Combined With Venetoclax in AML: The PRISM Risk ModelCurtis A Lachowiez, Joshua F Zeidner, Jad Othman, et al.

Pageof 4